(Total Views: 590)
Posted On: 02/15/2019 10:14:32 AM
Post# of 36549
Labry’s fund- the investor. Thomas TJ Silverman their main guy.
Little busy right now but I’ll guess acquisition/merger with Markers “Tappimmune” and the other neo antigen deal with Third Rock’s IPO launched Neon Therapeutics. https://endpts.com/neoantigen-pioneer-neon-th...treatment/
A very full agenda for the conference call!
Little busy right now but I’ll guess acquisition/merger with Markers “Tappimmune” and the other neo antigen deal with Third Rock’s IPO launched Neon Therapeutics. https://endpts.com/neoantigen-pioneer-neon-th...treatment/
A very full agenda for the conference call!
(0)
(0)Scroll down for more posts ▼
